lenvatinib,sorafenib,bevacizumab,atezolizumab
roche,bayer,eisai
[]
lenvatinib following progression on immunotherapy demonstrates efficacy in second-line hcc #hpbcsm #gi23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.